Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–30. https://doi.org/10.1056/NEJM199912023412303.
Article CAS PubMed Google Scholar
Heinbokel T, Elkhal A, Liu G, Edtinger K, Tullius SG. Immunosenescence and organ transplantation. Transplant Rev (Orlando). 2013;27(3):65–75. https://doi.org/10.1016/j.trre.2013.03.001.
Smits JM, Persijn GG, van Houwelingen HC, Claas FH, Frei U. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant. 2002;2(7):664–70. https://doi.org/10.1034/j.1600-6143.2002.20713.x.
Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002;2(8):701–11. https://doi.org/10.1034/j.1600-6143.2002.20804.x.
Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003;3(Suppl 4):114–25. https://doi.org/10.1034/j.1600-6143.3.s4.11.x.
Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh CR. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant. 2009;24(3):1039–47. https://doi.org/10.1093/ndt/gfn667.
Heldal K, Hartmann A, Leivestad T, Svendsen MV, Foss A, Lien B, et al. Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity. Transplantation. 2009;87(7):1045–51. https://doi.org/10.1097/TP.0b013e31819cdddd.
Lai X, Chen G, Qiu J, Wang C, Chen L. Recipient-related risk factors for graft failure and death in elderly kidney transplant recipients. PLoS One. 2014;9(11): e112938. https://doi.org/10.1371/journal.pone.0112938.
Article ADS CAS PubMed PubMed Central Google Scholar
Artiles A, Dominguez A, Subiela JD, Boissier R, Campi R, Prudhomme T, et al. Kidney transplant outcomes in elderly population: a systematic review and meta-analysis. Eur Urol Open Sci. 2023;51:13–25. https://doi.org/10.1016/j.euros.2023.02.011.
Article PubMed PubMed Central Google Scholar
So S, Au EHK, Lim WH, Lee VWS, Wong G. Factors influencing long-term patient and allograft outcomes in elderly kidney transplant recipients. Kidney Int Rep. 2021;6(3):727–36. https://doi.org/10.1016/j.ekir.2020.11.035.
Lemoine M, Titeca Beauport D, Lobbedez T, Choukroun G, Hurault de Ligny B, Hazzan M, et al. Risk factors for early graft failure and death after kidney transplantation in recipients older than 70 years. Kidney Int Rep. 2019;4(5):656–66. https://doi.org/10.1016/j.ekir.2019.01.014.
Article PubMed PubMed Central Google Scholar
Jankowska M, Bzoma B, Malyszko J, Malyszko J, Slupski M, Kobus G, et al. Early outcomes and long-term survival after kidney transplantation in elderly versus younger recipients from the same donor in a matched-pairs analysis. Medicine (Baltimore). 2021;100(51): e28159. https://doi.org/10.1097/MD.0000000000028159.
Article CAS PubMed Google Scholar
Gill JS, Tonelli M, Johnson N, Kiberd B, Landsberg D, Pereira BJ. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation. Kidney Int. 2005;68(5):2345–51. https://doi.org/10.1111/j.1523-1755.2005.00696.x.
Hemmersbach-Miller M, Alexander BD, Sudan DL, Pieper C, Schmader KE. Single-center analysis of infectious complications in older adults during the first year after kidney transplantation. Eur J Clin Microbiol Infect Dis. 2019;38(1):141–8. https://doi.org/10.1007/s10096-018-3405-5.
Oh SJ, Lee JK, Shin OS. Aging and the immune system: the impact of immunosenescence on viral infection, immunity and vaccine immunogenicity. Immune Netw. 2019;19(6): e37. https://doi.org/10.4110/in.2019.19.e37.
Article PubMed PubMed Central Google Scholar
Pera A, Campos C, Lopez N, Hassouneh F, Alonso C, Tarazona R, et al. Immunosenescence: implications for response to infection and vaccination in older people. Maturitas. 2015;82(1):50–5. https://doi.org/10.1016/j.maturitas.2015.05.004.
Article CAS PubMed Google Scholar
Lian J, Yue Y, Yu W, Zhang Y. Immunosenescence: a key player in cancer development. J Hematol Oncol. 2020;13(1):151. https://doi.org/10.1186/s13045-020-00986-z.
Article CAS PubMed PubMed Central Google Scholar
Fulop T, Larbi A, Witkowski JM, Kotb R, Hirokawa K, Pawelec G. Immunosenescence and cancer. Crit Rev Oncog. 2013;18(6):489–513. https://doi.org/10.1615/critrevoncog.2013010597.
Fane M, Weeraratna AT. How the ageing microenvironment influences tumour progression. Nat Rev Cancer. 2020;20(2):89–106. https://doi.org/10.1038/s41568-019-0222-9.
Article CAS PubMed Google Scholar
Costantini E, D’Angelo C, Reale M. The role of immunosenescence in neurodegenerative diseases. Mediators Inflamm. 2018;2018:6039171. https://doi.org/10.1155/2018/6039171.
Article CAS PubMed PubMed Central Google Scholar
Amoriello R, Mariottini A, Ballerini C. Immunosenescence and autoimmunity: exploiting the T-Cell Receptor Repertoire to Investigate the Impact of Aging on Multiple Sclerosis. Front Immunol. 2021;12: 799380. https://doi.org/10.3389/fimmu.2021.799380.
Article CAS PubMed PubMed Central Google Scholar
Tae YuH, Youn JC, Lee J, Park S, Chi HS, Lee J, et al. Characterization of CD8(+)CD57(+) T cells in patients with acute myocardial infarction. Cell Mol Immunol. 2015;12(4):466–73. https://doi.org/10.1038/cmi.2014.74.
Mella A, Mariano F, Dolla C, Gallo E, Manzione AM, Di Vico MC, et al. Bacterial and Viral Infection and Sepsis in Kidney Transplanted Patients. Biomedicines. 2022. https://doi.org/10.3390/biomedicines10030701.
Article PubMed PubMed Central Google Scholar
Fishman JA. Opportunistic infections–coming to the limits of immunosuppression? Cold Spring Harb Perspect Med. 2013;3(10): a015669. https://doi.org/10.1101/cshperspect.a015669.
Article CAS PubMed PubMed Central Google Scholar
Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs. 2007;67(8):1167–98. https://doi.org/10.2165/00003495-200767080-00006.
Article CAS PubMed Google Scholar
Cheung CY, Tang SCW. An update on cancer after kidney transplantation. Nephrol Dial Transplant. 2019;34(6):914–20. https://doi.org/10.1093/ndt/gfy262.
Gallagher MP, Kelly PJ, Jardine M, Perkovic V, Cass A, Craig JC, et al. Long-term cancer risk of immunosuppressive regimens after kidney transplantation. J Am Soc Nephrol. 2010;21(5):852–8. https://doi.org/10.1681/ASN.2009101043.
Article PubMed PubMed Central Google Scholar
Xia M, Yang H, Tong X, Xie H, Cui F, Shuang W. Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J Diabetes Investig. 2021;12(1):109–22. https://doi.org/10.1111/jdi.13317.
Ghisdal L, Van Laecke S, Abramowicz MJ, Vanholder R, Abramowicz D. New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care. 2012;35(1):181–8. https://doi.org/10.2337/dc11-1230.
Article CAS PubMed Google Scholar
Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7(1):158–65. https://doi.org/10.1681/ASN.V71158.
Article CAS PubMed Google Scholar
Devine PA, Courtney AE, Maxwell AP. Cardiovascular risk in renal transplant recipients. J Nephrol. 2019;32(3):389–99. https://doi.org/10.1007/s40620-018-0549-4.
Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11(11):2279–96. https://doi.org/10.1111/j.1600-6143.2011.03754.x.
Article CAS PubMed PubMed Central Google Scholar
Xia T, Zhu S, Wen Y, Gao S, Li M, Tao X, et al. Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis. Drug Des Devel Ther. 2018;12:417–28. https://doi.org/10.2147/DDDT.S149340.
留言 (0)